Amy Jabanoski

Amy Jabanoski has a diverse work experience, beginning in 2000 as a Project Monitor at LabCorp Clinical Trials. Amy then transitioned to roles in chiropractic care before moving into the pharmaceutical industry. Their most recent positions include Executive Director roles at LEXEO Therapeutics, Madrigal Pharmaceuticals, and Amicus Therapeutics, where they specialized in medical writing and regulatory affairs.

Amy Jabanoski obtained a Bachelor of Science degree in Animal Sciences from Rutgers University. Amy then pursued a Doctor of Chiropractic degree from Palmer College of Chiropractic. In addition, they took courses in Biomedical Informatics at UMDNJ. Amy has received various certifications, including being a licensed Chiropractic Physician and Chiropractor. Amy also holds certifications in Regulatory Affairs for Pharmaceuticals, Psychology of Leadership, and Physiotherapy.